Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy
Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy
复制标题
DOI:
10.1136/adc.2003.048504
复制
发表时间:
2005-01-01
影响因子:
5.2
通讯作者:
Appleton, R
中科院分区:
文献类型:
--
作者:
Tan, M;Appleton, R
Attention deficit hyperactivity disorder (ADHD) is characterised by inattention, impulsivity, and hyperactivity. The DSM-IV diagnosis of ADHD requires the presence of six of nine items or features that must have been present for at least six months, to have had an onset before 7 years of age, and to have resulted in significant distress or impairment.(1) In the general population, the prevalence of ADHD is approximately 5%.(2) There is a high co-morbidity of epilepsy and attentional and behavioural problems,(3 4) including ADHD, and it has been estimated that at least 20% of patients with epilepsy may present with features of ADHD.(5)